首页> 外国专利> benzoazepin-oxo acetic acid derivatives as ppar-delta agonists used to increase lower hdl-c, lower ldl-c and lower cholesterol

benzoazepin-oxo acetic acid derivatives as ppar-delta agonists used to increase lower hdl-c, lower ldl-c and lower cholesterol

机译:苯并ze庚因-氧代乙酸衍生物作为ppar-δ激动剂用于增加低度hdl-c,低度ldl-c和低胆固醇

摘要

BENZOAZEPIN-OXY-ACETIC ACID DERIVATIVES AS PPAR-DELTA AGONISTS USED FOR INCREASING HDL-C, LOWER LDL-C, AND LOWER CHOLESTEROL. The present invention relates to compounds of Formula (1) useful as PPAR agonists. Also described are pharmaceutical compositions and methods of treating one or more conditions including, but not limited to, diabetes, nephropathy, neuropathy, retinopathy, polycystic ovary syndrome, hypertension, ischemia, stroke, irritable bowel disorder, inflammation, cataract, cardiovascular disease, Metabolic Syndrome X, hyper-LDL-cholesterolemia, dyslipidemia (including hypertriglyceridemia, hypercholesterolemia, mixed hyperlipidemia, and hypo-HDL-cholesterolemia), atherosclerosis, obesity, and other disorders related to lipid metabolism and energy homeostasis complications of these using compounds of the invention.
机译:苯并ZE庚因-氧-乙酸衍生物作为PPAR-δ激动剂,用于增加HDL-C,LDL-C和胆固醇的降低。本发明涉及用作PPAR激动剂的式(1)化合物。还描述了治疗一种或多种病症的药物组合物和方法,所述病症包括但不限于糖尿病,肾病,神经病,视网膜病,多囊卵巢综合征,高血压,局部缺血,中风,肠易激综合征,炎症,白内障,心血管疾病,新陈代谢X综合征,高LDL胆固醇血症,血脂异常(包括高甘油三酸酯血症,高胆固醇血症,混合性高脂血症和低HDL胆固醇血症),动脉粥样硬化,肥胖症以及与脂质代谢和使用本发明化合物的能量稳态平衡并发症相关的其他病症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号